e-learning
resources
London 2016
Tuesday, 06.09.2016
Mixed-up imaging of various chest diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis
Antje Prasse (Hannover, Germany), Antje Prasse, Danny Jonigk, Tobias Welte, Bengel Frank, Derlin Thorsten
Source:
International Congress 2016 – Mixed-up imaging of various chest diseases
Session:
Mixed-up imaging of various chest diseases
Session type:
Thematic Poster
Number:
3828
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Antje Prasse (Hannover, Germany), Antje Prasse, Danny Jonigk, Tobias Welte, Bengel Frank, Derlin Thorsten. LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 3828
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Imaging of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014
Combining immunostaining with micro-computed tomography to visualise the 3D distribution of mast cells in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Imaging: how to recognise idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2014; 23:215-219
Year: 2014
IPFdatabase
– A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014
High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Quantitative lung T
1
mapping and oxygen enhanced MRI in IPF
Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI
Year: 2014
Prognostic value of dual-time-point
18
F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
LATE-BREAKING ABSTRACT: Inhibition of MAP3K19 - A novel therapeutic approach for treatment of IPF
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Progressive TLC loss after unilateral lung transplantation in IPF: Functional respiratory imaging differentiates between transplanted and native lung
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
LATE-BREAKING ABSTRACT: Diffusion-weighted hyperpolarised gas MRI in idiopathic pulmonary fibrosis: Reproducibility and clinical significance
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
LATE-BREAKING ABSTRACT: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Changes in the small airways in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Immunoproteasome expression in pulmonary fibrosis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept